PhD Student, Department of Bioengineering, Imperial College London (2026-present), co-supervised by Dr Jun Ishihara and Dr Sam Au.

MRes Cancer Technology, Imperial College London (2024).

BSc Biological Sciences, Carnegie Mellon University (2023).

Before starting his PhD, Amir worked as a primary scientist at Avigen, an Imperial College London spinout specialising in microfluidic technologies for immunotherapy development. His current research focuses on developing a vascularised human organoid-on-chip platform to investigate how bispecific antibodies influence T-cell trafficking, tumour infiltration and anti-tumour function within the tumour microenvironment.